BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 27383830)

  • 1. B7-H4 expression indicates poor prognosis of oral squamous cell carcinoma.
    Wu L; Deng WW; Yu GT; Mao L; Bu LL; Ma SR; Liu B; Zhang WF; Sun ZJ
    Cancer Immunol Immunother; 2016 Sep; 65(9):1035-45. PubMed ID: 27383830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Expression of LAMTOR5 Predicts Poor Prognosis and Is Associated with Lymph Node Metastasis of Head and Neck Squamous Cell Carcinoma.
    Yang QC; Wu CC; Cao LY; Xiao Y; Li H; Liu B; Sun ZJ
    Int J Med Sci; 2019; 16(6):783-792. PubMed ID: 31337951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programmed cell death-ligand 1 expression in oral squamous cell carcinoma is associated with an inflammatory phenotype.
    Satgunaseelan L; Gupta R; Madore J; Chia N; Lum T; Palme CE; Boyer M; Scolyer RA; Clark JR
    Pathology; 2016 Oct; 48(6):574-80. PubMed ID: 27590194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of FAM3C is associated with poor prognosis in oral squamous cell carcinoma.
    Wu CC; Xiao Y; Li H; Mao L; Deng WW; Yu GT; Zhang WF; Sun ZJ
    Pathol Res Pract; 2019 Apr; 215(4):772-778. PubMed ID: 30683473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of CD168 is related to poor prognosis in oral squamous cell carcinoma.
    Zhu SW; Wang S; Wu ZZ; Yang QC; Chen DR; Wan SC; Sun ZJ
    Oral Dis; 2022 Mar; 28(2):364-372. PubMed ID: 33386685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a Favorable Prognostic Subgroup in Oral Squamous Cell Carcinoma: Characterization of ITGB4/PD-L1
    Ma SR; Liu JF; Jia R; Deng WW; Jia J
    Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of VISTA correlated with immunosuppression and synergized with CD8 to predict survival in human oral squamous cell carcinoma.
    Wu L; Deng WW; Huang CF; Bu LL; Yu GT; Mao L; Zhang WF; Liu B; Sun ZJ
    Cancer Immunol Immunother; 2017 May; 66(5):627-636. PubMed ID: 28236118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of ATAD2 indicates Poor Prognosis in Oral Squamous Cell Carcinoma.
    Wang XL; Wang S; Wu ZZ; Yang QC; Li H; Xiong HG; Wan SC; Sun ZJ
    Int J Med Sci; 2020; 17(11):1598-1609. PubMed ID: 32669963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of caldesmon is associated with lymph node metastasis and poorer prognosis in patients with oral cavity squamous cell carcinoma.
    Chang KP; Wang CL; Kao HK; Liang Y; Liu SC; Huang LL; Hseuh C; Hsieh YJ; Chien KY; Chang YS; Yu JS; Chi LM
    Cancer; 2013 Nov; 119(22):4003-11. PubMed ID: 23963810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD317 Signature in Head and Neck Cancer Indicates Poor Prognosis.
    Yang LL; Wu L; Yu GT; Zhang WF; Liu B; Sun ZJ
    J Dent Res; 2018 Jul; 97(7):787-794. PubMed ID: 29486141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of Golgi Phosphoprotein 2 Is Associated With Poor Prognosis in Oral Squamous Cell Carcinoma.
    Li H; Yang LL; Xiao Y; Deng WW; Chen L; Wu L; Zhang WF; Sun ZJ
    Am J Clin Pathol; 2018 May; 150(1):74-83. PubMed ID: 29788173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant association of increased PD-L1 and PD-1 expression with nodal metastasis and a poor prognosis in oral squamous cell carcinoma.
    Maruse Y; Kawano S; Jinno T; Matsubara R; Goto Y; Kaneko N; Sakamoto T; Hashiguchi Y; Moriyama M; Toyoshima T; Kitamura R; Tanaka H; Oobu K; Kiyoshima T; Nakamura S
    Int J Oral Maxillofac Surg; 2018 Jul; 47(7):836-845. PubMed ID: 29395669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B7-H4 facilitates proliferation of esophageal squamous cell carcinoma cells through promoting interleukin-6/signal transducer and activator of transcription 3 pathway activation.
    Chen X; Wang L; Wang W; Zhao L; Shan B
    Cancer Sci; 2016 Jul; 107(7):944-54. PubMed ID: 27088889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) association with lymph node metastasis predicts poor survival in oral squamous cell carcinoma patients.
    Velmurugan BK; Yeh KT; Lee CH; Lin SH; Chin MC; Chiang SL; Wang ZH; Hua CH; Tsai MH; Chang JG; Ko YC
    Oncotarget; 2016 Mar; 7(10):10879-90. PubMed ID: 26918356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma.
    Borgmann M; Oetting A; Meyer F; Möckelmann N; Droste C; von Bargen CM; Möller-Koop C; Witt M; Borgmann K; Rothkamm K; Betz C; Münscher A; Clauditz TS; Rieckmann T
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3383-3393. PubMed ID: 35941227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Concordant Disruption of B7/CD28 Immune Regulators Predicts the Prognosis of Oral Carcinomas.
    Chang SR; Chou CH; Liu CJ; Lin YC; Tu HF; Chang KW; Lin SC
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of programmed cell death-ligand 1 in oral squamous cell carcinoma and oral leukoplakia is associated with disease progress and CD8+ tumor-infiltrating lymphocytes.
    Chen XJ; Tan YQ; Zhang N; He MJ; Zhou G
    Pathol Res Pract; 2019 Jun; 215(6):152418. PubMed ID: 31027907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Expression Patterns and Associated Clinical Parameters of Human Endogenous Retrovirus-H Long Terminal Repeat-Associating Protein 2 and Transmembrane and Immunoglobulin Domain Containing 2 in Oral Squamous Cell Carcinoma.
    Xiao Y; Li H; Yang LL; Mao L; Wu CC; Zhang WF; Sun ZJ
    Dis Markers; 2019; 2019():5421985. PubMed ID: 31089395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
    Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H
    J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VISTA blockade alleviates immunosuppression of MDSCs in oral squamous cell carcinoma.
    Liu J; Lin WP; Xiao Y; Yang QC; Bushabu Fidele N; Yu HJ; Sun ZJ
    Int Immunopharmacol; 2023 Dec; 125(Pt A):111128. PubMed ID: 37907049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.